Minerva Surgical, Inc. (UTRS) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 3 recommend buying, 0 recommend holding, and 1 recommend selling.
The analyst consensus price target for UTRS is $100.00, representing a +99,999,900.0% upside from the current price of $0.0001. Price targets range from a low of $100.00 to a high of $100.00.
